PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.768
https://www.valueinhealthjournal.com/article/S1098-3015(12)02481-3/fulltext
Title :
PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02481-3&doi=10.1016/j.jval.2012.08.768
First page :
A329
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
280